back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-08 15:03 Tx date 2024-05-06 |
$ACST
Acasti Pharma Inc. |
Macdonald, Robert Loch
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,380 vol |
85,380 | |
| Filed 2024-05-08 15:01 Tx date 2024-05-06 |
$ACST
Acasti Pharma Inc. |
DelAversano, Robert John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,500 vol |
46,500 | |
| Filed 2024-05-08 15:00 Tx date 2024-05-06 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+128,770 vol |
453,624 | |
| Filed 2024-05-08 14:57 Tx date 2024-05-06 |
$ACST
Acasti Pharma Inc. |
D'Andrea, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,740 vol |
61,740 | |
| Filed 2024-05-08 14:55 Tx date 2024-05-06 |
$ACST
Acasti Pharma Inc. |
Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,740 vol |
61,740 | |
| Filed 2024-01-08 14:49 Tx date 2024-01-05 |
$ACST
Acasti Pharma Inc. |
DelAversano, Robert John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
42,000 | ||
| Filed 2023-12-20 19:13 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,017 | |
| Filed 2023-12-20 19:11 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,668 vol |
324,854 | |
| Filed 2023-12-20 19:10 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
22,500 | |
| Filed 2023-12-20 19:09 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2023-12-20 19:08 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
22,500 | |
| Filed 2023-12-20 19:07 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2023-12-20 19:07 Tx date 2023-10-10 |
$ACST
Acasti Pharma Inc. |
Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-20 19:06 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
22,500 | |
| Filed 2023-12-20 19:05 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2023-12-20 19:05 Tx date 2023-10-10 |
$ACST
Acasti Pharma Inc. |
Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-28 12:01 Tx date 2023-09-25 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Warrants Private Offering Sept 2023
11 - Acquisition or disposition carried out privately
|
+422,732 vol |
422,732 | |
| Filed 2023-09-28 12:00 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Warrants Private Offering Sept 2023
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-28 12:00 Tx date 2023-09-25 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
11 - Acquisition or disposition carried out privately
|
$1,250,001
+676,371 vol $1.85 each |
1,188,076 | |
| Filed 2023-09-05 16:32 Tx date 2023-08-31 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$781.05
+381 vol $2.05 each |
381 |